<SEC-DOCUMENT>0001019687-14-000788.txt : 20140310
<SEC-HEADER>0001019687-14-000788.hdr.sgml : 20140310
<ACCEPTANCE-DATETIME>20140310171706
ACCESSION NUMBER:		0001019687-14-000788
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20140305
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20140310
DATE AS OF CHANGE:		20140310

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RestorGenex Corp
		CENTRAL INDEX KEY:			0001053691
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-AMUSEMENT & RECREATION SERVICES [7900]
		IRS NUMBER:				300645032
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-24477
		FILM NUMBER:		14681886

	BUSINESS ADDRESS:	
		STREET 1:		1800 CENTURY PARK EAST, 6TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067
		BUSINESS PHONE:		310.526.8700

	MAIL ADDRESS:	
		STREET 1:		1800 CENTURY PARK EAST, 6TH FLOOR
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90067

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Stratus Media Group, Inc
		DATE OF NAME CHANGE:	20080722

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FERIS INTERNATIONAL, INC.
		DATE OF NAME CHANGE:	20080228

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TITAN MOTORCYCLE CO OF AMERICA INC
		DATE OF NAME CHANGE:	19980615
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>restorgenex_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">FORM
8-K</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PURSUANT TO SECTION 13 OR 15(d) OF THE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of Report (Date of earliest event reported):
March 5, 2014</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt">RESTORGENEX
CORPORATION</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: top">
    <TD STYLE="width: 33%; text-align: center">NEVADA</td>
    <TD STYLE="width: 34%; text-align: center">000-24477</td>
    <TD STYLE="width: 33%; text-align: center">86-0776876</td></tr>
<tr style="vertical-align: top">
    <TD STYLE="text-align: center">(State or other jurisdiction of incorporation)</td>
    <TD STYLE="text-align: center">(Commission File Number)</td>
    <TD STYLE="text-align: center">(IRS Employer Identification No.)</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">1800 Century Park East</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">6<SUP>th</SUP> Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Los Angeles, California 90067</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(310) 526-8700</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&rsquo;s telephone number, including
area code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD>Written communications pursuant to Rule 425 under the Securities Act of 1933 (17 CFR 230.425)</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">o</FONT></TD><TD>Pre-commencement communications pursuant to Rule 13e-4(e) under the Exchange Act (17 CFR 240.13e-4(c))</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: bold 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 15%">Item 1.01</TD>
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 85%">Entry into a Material Definitive Agreement</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 5 2014, the Company entered into
an Employment Agreement with Stephen M. Simes (the &ldquo;Simes Employment Agreement&rdquo;) pursuant to which Mr. Simes was appointed
Chief Executive Officer of the Company. The Simes Employment Agreement is for an initial term of three years, subject to extension
as provided therein. Mr. Simes is to receive a base salary at an annual rate of $425,000 with at least annual review and base salary
increases as approved by the Board of Director or its Compensation Committee. He will have the opportunity to earn a bonus with
respect to each year during his employment based upon achievement of performance objectives set by the Board or the Compensation
Committee after consultation with Mr. Simes with a target bonus opportunity of 60% of base salary for each year. He will also receive
an initial grant of options to purchase 50,000,000 pre-reverse stock split at a pre-reverse split exercise price of $0.02 per share
which will vest quarterly over the initial three-year term of his employment.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: bold 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 15%">Item 5.02</TD>
    <TD STYLE="width: 85%">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective March 5, 2014, the Company appointed
Stephen M. Simes as Chief Executive Officer and director. Mr.&nbsp;Simes replaces Jerold Rubinstein who resigned as Chief Executive
Officer effective with Mr.&nbsp;Simes appointment. Mr.&nbsp;Rubenstein remains as a director and Chairman of the Audit Committee.
Mr.&nbsp;Simes, age 62, served as Vice Chairman, President, Chief Executive Officer and a director of BioSante Pharmaceuticals,
Inc. from 1998 until June 29, 2013 when BioSante merged with ANIP Acquisition Company, d/b/a ANI Pharmaceuticals, Inc. BioSante,
whose stock was listed on The NASDAQ Global Markets, was a specialty pharmaceutical company focused on developing products for
female sexual health, menopause, contraception, and male hypogonadism. From 1994 to 1997, Mr. Simes was President, Chief Executive
Officer and a Director of Unimed Pharmaceuticals, Inc., (currently a wholly owned subsidiary of Abbott Laboratories) a company
with a product focus on infectious diseases, AIDS, endocrinology and oncology. From 1989 to 1993, Mr. Simes was Chairman, President
and Chief Executive Officer of Gynex Pharmaceuticals, Inc., a company which concentrated on the AIDS, endocrinology, urology and
growth disorders markets. In 1993, Gynex was acquired by Savient Pharmaceuticals Inc. (formerly Bio-Technology General Corp.),
and from 1993 to 1994, Mr. Simes served as Senior Vice President and director of Savient Pharmaceuticals Inc. Mr. Simes's career
in the pharmaceutical industry started in 1974 with G.D. Searle &amp; Co. (now a part of Pfizer Inc.).</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: bold 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 15%">Item 8.01</TD>
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 85%">Other Events</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On March 10, 2014, the Company issued a
press release with respect to the foregoing. A copy of the press release is furnished as Exhibit 99.1 hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: bold 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 15%">Item 9.01</TD>
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 85%">Financial Statements and Exhibits</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 10pt; text-align: center; width: 15%">(d)</TD>
    <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 85%">Exhibits</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt"><u>Exhibit No.</u></td>
    <TD STYLE="width: 85%; padding-top: 6pt; padding-right: 5.4pt"><u>Description</u></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 13.5pt">10.01</td>
    <td style="padding-top: 6pt; padding-bottom: 6pt">Executive Employment Agreement by and between the Company and Stephen M. Simes.</td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 13.5pt">99.1</td>
    <td style="padding-top: 6pt; padding-bottom: 6pt">Press Release issued by the Company on March 10, 2014.</td></tr>
</table>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">Date: March 10, 2014</TD>
    <TD COLSPAN="2">RESTORGENEX CORPORATION</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">&nbsp;</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Stephen M. Simes</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Stephen M. Simes, Chief Executive Officer<BR></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Index of Exhibits</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<table cellspacing="0" cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<tr style="vertical-align: top">
    <td style="width: 15%; padding-top: 6pt; padding-right: 5.4pt; padding-left: 5.4pt"><u>Exhibit No.</u></td>
    <TD STYLE="width: 85%; padding-top: 6pt; padding-right: 5.4pt"><u>Description</u></td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 13.5pt">10.01</td>
    <td style="padding-top: 6pt; padding-bottom: 6pt">Executive Employment Agreement by and between the Company and Stephen M. Simes.</td></tr>
<tr style="vertical-align: top">
    <td style="padding-top: 6pt; padding-bottom: 6pt; padding-left: 13.5pt">99.1</td>
    <td style="padding-top: 6pt; padding-bottom: 6pt">Press Release issued by the Company on March&nbsp;10, 2014.</td></tr>
</table>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.01
<SEQUENCE>2
<FILENAME>restorgenex_ex1001.htm
<DESCRIPTION>EXECUTIVE EMPLOYMENT AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">EXHIBIT 10.01</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXECUTIVE EMPLOYMENT AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This EXECUTIVE EMPLOYMENT AGREEMENT (this
&ldquo;Agreement&rdquo;) is made and entered into as of the 5<SUP>th</SUP> day of March, 2014 (the &ldquo;Effective Date&rdquo;),
by and between Stratus Media Group, Inc., a Nevada corporation with an address at 1800 Century Park East, 6th Floor, Los Angeles,
CA 90067 (the &ldquo;Company&rdquo;), and Stephen M. Simes, a natural person (&ldquo;Executive&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">W I T N E S E T H:</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, Executive desires to be employed
by the Company as its Chief Executive Officer (the &ldquo;Position&rdquo;) and the Company wishes to employ Executive in such capacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW, THEREFORE, in consideration of the
foregoing recitals and the respective covenants and agreements of the parties contained in this document, the Company and Executive
hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&#9;Employment and Duties. The Company
agrees to employ and Executive agrees to serve in the Position effective as of the Effective Date. The duties and responsibilities
of Executive shall include the duties and responsibilities as the Board of Directors of the Company (the &ldquo;Board&rdquo;) may
from time to time assign to Executive comparable with the duties and responsibilities of a Chief Executive Officer of a corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Executive shall devote substantially all
of his business hours, and during such time, will make the best use of Executive&rsquo;s attention and energies to the business
of the Company. Nothing in this Section 1 shall prohibit Executive from (a) subject to the Board&rsquo;s approval, serving as a
member of the board of directors of up to two (2) for-profit entities, (b) serving as a director or trustee of any charitable or
educational organization or (c) engaging in civic, educational, religious, charitable or other community or non-profit activities;
provided, that none of such activities materially interfere with the performance of the duties and responsibilities of Executive
under this Agreement and do not violate the terms of Section 13.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Effective as of the Effective Date, the
Board will expand the size of the Board and appoint Executive as a director of the Company to fill the vacancy created as a result
of the increase in the size of the Board and thereafter during the Employment Period (as defined below), the Board will continue
to nominate Executive as a nominee for director and solicit proxies for his election for so long as Executive remains Chief Executive
Officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.&#9;Employment Period. The Executive&rsquo;s
employment under this Agreement will commence on the Effective Date and will continue through the third (3rd) anniversary of such
date (the &ldquo;Initial Term Expiration Date&rdquo;); provided, that upon the Initial Term Expiration Date, and each subsequent
anniversary of such date, if applicable, the term of the Executive&rsquo;s employment under this Agreement will automatically be
extended by one (1) year, unless either party provides the other party with written notice at least ninety (90) days before the
Initial Term Expiration Date, or such subsequent anniversary of such date, if applicable, of such party&rsquo;s decision not to
extend the term of employment under this Agreement. Notwithstanding the foregoing, the Executive&rsquo;s employment under this
Agreement may be terminated at any time, before or after the Initial Term Expiration Date, in accordance with Section 11. The term
of the Executive&rsquo;s employment under this Agreement is the &ldquo;Employment Period.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.&#9;Place of Employment. The principal
location of Executive&rsquo;s employment shall be in the Chicago, Illinois (and its suburban) area. The parties acknowledge, however,
that Executive may be required to travel in connection with the performance of his duties hereunder and shall spend substantial
time at the Company&rsquo;s Boston office as necessary to perform his duties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.&#9;Base Salary. For all services to be
rendered by Executive pursuant to this Agreement, the Company agrees to pay Executive during the Employment Period a base salary
(the &ldquo;Base Salary&rdquo;) at an annual rate of at least Four Hundred Twenty-Five Thousand Dollars ($425,000) during the Employment
Period, with at least annual review and Base Salary increases as approved by the Board or the Compensation Committee of the Board
(the &ldquo;Compensation Committee&rdquo;). In no event shall the Base Salary be decreased during the Employment Period. The Base
Salary shall be paid in periodic installments in accordance with the Company&rsquo;s regular payroll practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.&#9;Annual Bonus. Executive shall have
the opportunity to earn a bonus with respect to each year during the Employment Period, based upon Executive&rsquo;s achievement
of performance objectives set by the Board or the Compensation Committee after consultation with Executive, with a targeted bonus
opportunity of sixty percent (60%) of Executive&rsquo;s Base Salary for such year (the &ldquo;Annual Bonus&rdquo;), with the potential
to earn a higher bonus for above target performance. The foregoing notwithstanding, the amount of any such grant shall be at the
discretion of the Board of Directors. Any Annual Bonus shall be paid no later than March 15th of the calendar year immediately
following the calendar year to which the Annual Bonus relates. The amount of the Annual Bonus targeted bonus opportunity shall
be reviewed by the Board or the Compensation Committee on an annual basis. In no event shall the Annual Bonus targeted bonus opportunity
be less than sixty percent (60%) during the Employment Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.&#9;Severance Compensation. Upon termination
of Executive&rsquo;s employment during the Employment Period by the Company, other than for Cause or by the Executive for Good
Reason, Executive shall receive the severance benefits described in this Section 6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#9;Executive shall receive an amount
equal to twelve (12) months of Executive&rsquo;s monthly Base Salary in effect as of the date of termination plus the pro-rata
Annual Bonus amount of sixty percent (60%) of annual Base Salary, (the &ldquo;Separation Payment&rdquo;); provided, that no later
than fifty (50) days after Executive terminates employment he executes an agreement releasing the Company and its affiliates from
any liability associated with this Agreement substantially in the form attached as Exhibit A (or such other form mutually agreed
upon by the parties ) (the &ldquo;Release&rdquo;) and all time periods imposed by law permitting cancellation or revocation of
such Release by Executive shall have passed or expired. Subject to anything to the contrary in Section 11(d)(3) and Section 15,
the Separation Payment shall be paid in accordance with the customary payroll practices of the Company with the first payment made
on the payroll date that first follows the date the revocation period of the Release has ended (without any revocation by Executive).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#9;Subject to Executive&rsquo;s timely
election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (&ldquo;COBRA&rdquo;),
with respect to the Company&rsquo;s group health insurance plans in which the Executive (and his spouse and other dependents) participated
immediately prior to the termination date (the &ldquo;COBRA Continuation Coverage&rdquo;), the Company will reimburse Executive
for the amount Executive pays for COBRA Continuation Coverage for himself and his spouse and other dependents during the Premium
Reimbursement Period (the &ldquo;COBRA Premium Reimbursements&rdquo;). The &ldquo;Premium Reimbursement Period&rdquo; is the period
that begins on the date Executive terminates employment and ends on the earlier of: (1) the twelfth (12th) month after the termination
date and (2) the date on which Executive&rsquo;s eligibility for COBRA Continuation Coverage under the Company&rsquo;s group health
plans ends (which may be the date on which Executive becomes covered by another employer&rsquo;s group health plan because of reemployment
or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#9;If Executive experiences a Change
of Control Termination during the Employment Period, then Executive will be entitled to the benefits described in this Section
6(c), in lieu of the benefits described in Sections 6(a) and 6(b). A &ldquo;Change of Control Termination&rdquo; means termination
of Executive&rsquo;s employment by Executive for Good Reason or any involuntary termination of Executive&rsquo;s employment by
the Company (or its successor), other than for Cause, within the period beginning on the date of a Change of Control and ending
twelve (12) months from the date of the Change of Control or prior to a Change of Control if Executive&rsquo;s termination of employment
was either a condition of the Change of Control or was at the request or insistence of a person related to the Change of Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&#9;Executive shall receive an amount
equal to twenty-four (24) months of Executive&rsquo;s monthly Base Salary in effect as of the date of termination plus two (2)
times the Annual Bonus amount of sixty percent (60%) of annual Base Salary (the &ldquo;Change of Control Separation Payment&rdquo;);
provided, that no later than fifty (50) days after Executive terminates employment he executes the Release and all time periods
imposed by law permitting cancellation or revocation of such Release by Executive shall have passed or expired. Subject to anything
to the contrary in Section 11(d)(3) and Section 15, the Change of Control Separation Payment shall be paid in a single lump sum
payment within ten (10) business days after Executive returns the signed Release and the revocation period has expired without
Executive revoking the Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&#9;Subject to Executive&rsquo;s timely
election of COBRA Continuation Coverage, the Company will reimburse Executive for the amount Executive pays for COBRA Continuation
Coverage during the Change of Control Premium Reimbursement Period (the &ldquo;Change of Control COBRA Premium Reimbursements&rdquo;).
The &ldquo;Change of Control Premium Reimbursement Period&rdquo; is the period that begins on the date Executive terminates employment
and ends on the earlier of: (1) the eighteenth (18th) month after the termination date and (2) the date on which Executive&rsquo;s
eligibility for COBRA continuation coverage under the Company&rsquo;s group health plans ends (which may be the date on which Executive
becomes covered by another employer&rsquo;s group health plan because of reemployment or otherwise).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#9;The Company shall deduct, from all
Separation Payments and Change of Control Severance Payments, all applicable taxes including income tax, FICA and FUTA, and other
appropriate deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">7.&#9;Equity Awards. Executive shall receive
an initial grant of Fifty Million (50,000,000) stock options to purchase the Company&rsquo;s common stock (subject to adjustment
for stock splits, stock dividends and other similar changes in the Company&rsquo;s common stock). Such initial stock option(s)
shall have a per share exercise price equal to the fair market value of a share of the Company&rsquo;s common stock on the date
of grant and shall vest quarterly while employed and over the three (3) initial term of Executive&rsquo;s employment. In addition
to such initial stock option(s), the Board or Compensation Committee shall review Executive&rsquo;s long-term compensation at least
annually and, after consultation with Executive, shall consider granting annual additional equity awards under the Status Media
Group, Inc. Incentive Compensation Plan (or any successor or replacement plan adopted by the Board and approved by the stockholders
of the Company) (the &ldquo;Plan&rdquo;) as the Board or Compensation Committee may from time to time determine (the &ldquo;Equity
Awards&rdquo;). The Equity Awards shall be subject to the applicable Plan terms and conditions; provided, however, that the vesting
of the Equity Awards shall accelerate and become immediately vested and exercisable upon a Change of Control and the Equity Awards
shall be subject to any additional terms and conditions as are provided herein or in any award agreement, which shall supersede
any conflicting provisions governing Equity Awards provided under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">8.&#9;Clawback Rights. All amounts paid
to Executive by the Company relating solely to incentive-based compensation granted during the Employment Period (collectively,
the &ldquo;Clawback Benefits&rdquo;) shall be subject to &ldquo;Clawback Rights&rdquo; as follows: during the period that Executive
is employed by the Company and upon the termination or expiration of Executive&rsquo;s employment and for a period of eighteen
(18) months thereafter, if any of the following events occur, Executive agrees to repay or surrender to the Company Clawback Benefits
if a restatement (a &ldquo;Restatement&rdquo;) of any financial results from which any Clawback Benefits to Executive shall have
been determined (such restatement resulting from material non-compliance of the Company with any financial reporting requirement
under the federal securities laws and shall not include a restatement of financial results resulting from subsequent changes in
accounting pronouncements or requirements which were not in effect on the date the financial statements were originally prepared),
then Executive agrees to immediately repay or surrender upon demand by the Company any Clawback Benefits which were determined
by reference to any Company financial results which were later restated, to the extent the Clawback Benefits amounts paid exceed
the Clawback Benefits amounts that would have been paid, based on the restatement of the Company&rsquo;s financial information
All Clawback Benefits amounts resulting from such Restatements shall be retroactively adjusted by the Compensation Committee (or
the Board, if there is no Compensation Committee) to take into account the restated results and if any excess portion of the Clawback
Benefits resulting from such restated results is not so repaid or surrendered by Executive within one hundred eighty (180) days
of the revised calculation being provided to Executive by the Company following a publicly announced restatement, the Company shall
have the right to take any and all action to effectuate such adjustment. For the avoidance of doubt, the Company and Executive
agree and acknowledge that this Section 8 is specifically limited to the Company clawing back only incentive-based compensation
when it is finally determined (in accordance with the timeline set forth herein), following a Restatement of the financial results
that, in the first instance, the incentive-based compensation should not have been paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The amount of Clawback Benefits to be repaid
or surrendered to the Company shall be reasonably determined by the Compensation Committee (or the Board, if there is no Compensation
Committee) and applicable law, rules and regulations. All determinations by the Compensation Committee (or the Board, if there
is no Compensation Committee) with respect to the Clawback Rights shall be final and binding on the Company and Executive. The
parties acknowledge it is their intention that the foregoing Clawback Rights as relates to Restatements conform in all respects
to the provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the &ldquo;Dodd Frank Act&rdquo;) and
requires recovery of all &ldquo;incentive-based&rdquo; compensation, pursuant to the provisions of the Dodd Frank Act and any and
all rules and regulations promulgated thereunder from time to time in effect. Accordingly, the terms and provisions of this Agreement
shall be deemed automatically amended from time to time to assure compliance with the Dodd Frank Act and such rules and regulation
as hereafter may be adopted and in effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">9.&#9;Expenses. Executive shall be entitled
to prompt reimbursement by the Company for all reasonable ordinary and necessary travel (including, but not limited to, travel
to the Company&rsquo;s Boston office), entertainment, and other expenses incurred by Executive while employed (in accordance with
the policies and procedures established by the Company for its senior executive officers) in the performance of his duties and
responsibilities under this Agreement; provided, that Executive shall properly account for such expenses in accordance with Company
policies and procedures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">10.&#9;Other Benefits; Vacation. During
the Employment Period, Executive shall be eligible to participate in incentive, stock purchase, savings, retirement (401(k)), and
welfare benefit plans including, without limitation, health, medical, dental, vision, life (including accidental death and dismemberment)
and disability insurance plans (collectively, &ldquo;Benefit Plans&rdquo;), in substantially the same manner and at substantially
the same levels as the Company makes such opportunities available to the Company&rsquo;s managerial or salaried executive employees.
During the Employment Period, Executive shall be entitled to accrue, on a pro rata basis, twenty-two (22) paid vacation days per
year, which if not taken will be carried forward. Vacation shall be taken at such times as are mutually convenient to Executive
and the Company and no more than ten (10) consecutive days shall be taken at any one time without the advance approval of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">11.&#9;Termination of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#9;Death. If Executive dies during the
Employment Period, this Agreement and Executive&rsquo;s employment with the Company shall automatically terminate and the Company
shall have no further obligations to Executive or his heirs, administrators or executors with respect to compensation and benefits
accruing thereafter, except for the obligation to pay to Executive&rsquo;s heirs, administrators or executors (1) any earned but
unpaid Base Salary, unpaid pro rata Annual Bonus for the current year through the date of death, reimbursement of any and all reasonable
expenses paid or incurred by Executive in connection with and related to the performance of his duties and responsibilities for
the Company during the period ending on the date of death and (2) any accrued but unused vacation time through the date of death
in accordance with Company policy (other than any limits on carry-over of vacation accruals that conflict with Section 10). The
Company shall deduct, from all payments made hereunder, all applicable taxes, including income tax, FICA and FUTA, and other appropriate
deductions. In addition, Executive&rsquo;s spouse and other dependents shall be entitled to COBRA Premium Reimbursements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#9;Disability. In the event that, during
the term of this Agreement Executive shall be prevented from performing his duties and responsibilities hereunder to the full extent
required by the Company by reason of Disability (as defined below), this Agreement and Executive&rsquo;s employment with the Company
shall automatically terminate and the Company shall have no further obligations or liability to Executive or his heirs, administrators
or executors with respect to compensation and benefits accruing thereafter, except for the obligation to pay Executive or his heirs,
administrators or executors (1) any earned but unpaid Base Salary, unpaid pro rata Annual Bonus for the current year through the
date of termination of employment, reimbursement of any and all reasonable expenses paid or incurred by Executive in connection
with and related to the performance of his duties and responsibilities for the Company during the period ending on the termination
date and (2) any accrued but unused vacation time through the termination date in accordance with Company policy (other than any
limits on carry-over of vacation accruals that conflict with Section 10). The Company shall deduct, from all payments made hereunder,
all applicable taxes, including income tax, FICA and FUTA, and other appropriate deductions through the last date of Executive&rsquo;s
employment with the Company. In addition, Executive shall be entitled to COBRA Premium Reimbursements. For purposes of this Agreement,
&ldquo;Disability&rdquo; shall mean a physical or mental disability that prevents the performance by Executive, with or without
reasonable accommodation, of his duties and responsibilities hereunder for a period of not less than an aggregate of three (3)
months during any twelve (12) consecutive months; provided, if Executive is a qualified person with a disability under the Americans
With Disabilities Act or applicable state law, the Company will make reasonable accommodations to the known physical or mental
limitations of Executive including, but not limited to, consideration of whether extending the three month period would constitute
a reasonable accommodation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#9;Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&#9;At any time during the Employment
Period, the Company may terminate this Agreement and Executive&rsquo;s employment hereunder for Cause. For purposes of this Agreement,
&ldquo;Cause&rdquo; shall consist of a termination due to the following, as specified in the written notice of termination (and
in each case following written notice a failure by Executive to cure within thirty (30) days of such notice except as to clauses
(E) or (F) which shall not be subject to cure: (A) Executive&rsquo;s failure to substantially perform the fundamental duties and
responsibilities associated with Executive&rsquo;s position, including Executive&rsquo;s failure or refusal to carry out reasonable
instructions; (B) Executive&rsquo;s material breach of any material written Company policy; (C) Executive&rsquo;s gross misconduct
in the performance of Executive&rsquo;s duties for the Company; (D) Executive&rsquo;s material breach of the terms of this Agreement;
(E) Executive&rsquo;s conviction of any fraudulent or felony criminal offense or any other criminal offense which reflects adversely
on the Company or reflects conduct or character that the Board reasonably concludes is inconsistent with continued employment;
or (F) Executive&rsquo;s conviction of any criminal conduct that is a &ldquo;statutory disqualifying event&rdquo; (as defined under
federal securities laws, rules and regulations).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&#9;Prior to any termination for Cause,
and following the thirty (30) day cure period provided for in Section 11(c)(1) hereof, Executive will be given five (5) business
days written notice specifying the alleged Cause event and will be entitled to appear (with counsel) before the full Board to present
information regarding his views on the Cause event, and after such hearing, there is at least a majority vote of the full Board
(other than Executive) to terminate him for Cause. After providing the notice in foregoing sentence, the Board may suspend Executive
with full pay and benefits until a final determination pursuant to this Section 11(c) has been made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(3)&#9;Upon termination of this Agreement
for Cause, the Company shall have no further obligations or liability to Executive or his heirs, administrators or executors with
respect to compensation and benefits thereafter, except for the obligation to pay Executive any earned but unpaid Base Salary,
reimbursement of any and all reasonable expenses paid or incurred by Executive in connection with and related to the performance
of his duties and responsibilities for the Company during the period ending on the termination date, and any accrued but unused
vacation time through the termination date in accordance with Company policy (other than any limits on carry-over of vacation accruals
that conflict with Section 10). The Company shall deduct, from all payments made hereunder, all applicable taxes, including income
tax, FICA and FUTA, and other appropriate deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#9;Good Reason and Without Cause.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&#9;At any time during the Employment
Period, subject to the conditions set forth in Section 11(d)(2) below, Executive may terminate this Agreement and Executive&rsquo;s
employment with the Company for &ldquo;Good Reason.&rdquo; For purposes of this Agreement, &ldquo;Good Reason&rdquo; shall mean
any of the following actions taken by the Company or a successor corporation or entity without Executive&rsquo;s consent: (A) material
reduction of Executive&rsquo;s base compensation; (B) material reduction in Executive&rsquo;s title, authority, duties or responsibilities;
(C) failure or refusal of a successor to the Company to materially assume the Company&rsquo;s obligations under this Agreement
in the event of a Change of Control; (D) subject to section 3 regarding travel to the Boston office, relocation of Executive&rsquo;s
the Job Site that results in an increase in Executive&rsquo;s one-way driving distance by more than fifty (50) miles from Executive&rsquo;s
then-current principal residence; or (E) any other material breach by the Company of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&#9;Executive shall not be entitled to
terminate this Agreement for Good Reason unless and until (i) he has delivered written notice to the Company within ninety (90)
days of the date upon which the facts giving rise to Good Reason occurred of his intention to terminate this Agreement and his
employment with the Company for Good Reason, which notice specifies in reasonable detail the circumstances claimed to provide the
basis for such termination for Good Reason, (ii) the Company shall not have eliminated the circumstances constituting Good Reason
within thirty (30) days of its receipt from Executive of such written notice and (iii) Executive terminates employment with the
Company no later than two (2) years after the initial date of the circumstances claimed to provide the basis for such termination
for Good Reason.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(3)&#9;In the event that Executive terminates
this Agreement and his employment with the Company for Good Reason or the Company terminates this Agreement and Executive&rsquo;s
employment with the Company without Cause, the Company shall pay or provide to Executive (or, following his death, to Executive&rsquo;s
heirs, administrators or executors) the Separation Payment and COBRA Premium Reimbursements or, if applicable, the Change of Control
Separation Payment and Change of Control COBRA Premium Reimbursements. The Company shall deduct, from all payments made hereunder,
all applicable taxes, including income tax, FICA and FUTA, and other appropriate deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&#9;Without &ldquo;Good Reason&rdquo;
by Executive. At any time during the term of this Agreement, Executive shall be entitled to terminate this Agreement and Executive&rsquo;s
employment with the Company without Good Reason by providing prior written notice of at least thirty (30) days to the Company.
Upon termination by Executive of this Agreement or Executive&rsquo;s employment with the Company without Good Reason, the Company
shall have no further obligations or liability to Executive or his heirs, administrators or executors with respect to compensation
and benefits thereafter, except for the obligation to pay Executive any earned but unpaid Base Salary, reimbursement of any and
all reasonable expenses paid or incurred by Executive in connection with and related to the performance of his duties and responsibilities
for the Company during the period ending on the termination date, and any accrued but unused vacation time through the termination
date in accordance with Company policy (other than any limits on carry-over of vacation accruals that conflict with Section 10).
The Company shall deduct, from all payments made hereunder, all applicable taxes, including income tax, FICA and FUTA, and other
appropriate deductions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&#9;Change of Control. For purposes of
this Agreement, &ldquo;Change of Control&rdquo; shall mean the occurrence of any one or more of the following: (i) the accumulation
(if over time, in any consecutive twelve (12) month period), whether directly, indirectly, beneficially or of record, by any individual,
entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended) of 50.1%
or more of the shares of the outstanding common stock of the Company, whether by merger, consolidation, sale or other transfer
of shares of Company common stock (other than a merger or consolidation where the stockholders of the Company prior to the merger
or consolidation are the holders of a majority of the voting securities of the entity that survives such merger or consolidation),
(ii) a sale of all or substantially all of the assets of the Company or (iii) during any period of twelve (12) consecutive months,
the individuals who, at the beginning of such period, constitute the Board, and any new director whose election by the Board or
nomination for election by the Company&rsquo;s stockholders was approved by a vote of at least two-thirds (2/3) of the directors
then still in office who either were directors at the beginning of the 12-month period or whose election or nomination for election
was previously so approved, cease for any reason to constitute at least a majority of the Board; provided, however, that the following
acquisitions shall not constitute a Change of Control for the purposes of this Agreement: (A) any acquisitions of Company common
stock or securities convertible, exercisable or exchangeable into Company common stock directly from the Company or (B) any acquisition
of Company common stock or securities convertible, exercisable or exchangeable into Company common stock by any employee benefit
plan (or related trust) sponsored by or maintained by the Company. Notwithstanding the foregoing, for purposes of determining whether
Executive has a Change of Control Termination, Change of Control will only occur if such event constitutes a &ldquo;Change in Control
Event&rdquo; as defined under Treasury Regulations issued under Code Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g)&#9;Any termination of Executive&rsquo;s
employment by the Company or by Executive (other than termination by reason of Executive&rsquo;s death) shall be communicated by
written Notice of Termination to the other party of this Agreement. For purposes of this Agreement, a &ldquo;Notice of Termination&rdquo;
shall mean a written notice which shall indicate the specific termination provision in this Agreement relied upon and shall set
forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive&rsquo;s employment
under the provision so indicated, provided, however, failure to provide timely notification shall not affect the employment status
of Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h)&#9;Regardless of whether Executive signs
and does not revoke the Release, Executive (or in the event of his death, Executive&rsquo;s estate) upon termination of employment
Executive will receive payment for (i) all reasonable expenses paid or incurred by Executive in connection with and related to
the performance of his duties and responsibilities for the Company during the period ending on the termination date, (ii) any accrued
but unused vacation time through the termination date in accordance with Company policy (other than any limits on carry-over of
vacation accruals that conflict with Section 10); and (iii) unpaid Base Salary earned through the termination date and unpaid pro
rata annual Bonus, if any, for the current year through the termination date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">12.&#9;Confidential Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#9;Disclosure of Confidential Information.
Executive recognizes, acknowledges and agrees that he has had and will continue to have access to secret and confidential information
regarding the Company, its subsidiaries and their respective businesses (&ldquo;Confidential Information&rdquo;), including but
not limited to, its products, methods, formulas, software code, patents, sources of supply, customer dealings, data, know-how,
trade secrets and business plans, provided such information is not in or does not hereafter become part of the public domain, or
become known to others through no fault of Executive. Executive acknowledges that such information is of great value to the Company,
is the sole property of the Company, and has been and will be acquired by him in confidence. In consideration of the obligations
undertaken by the Company herein, Executive will not, at any time, during or after his employment hereunder, reveal, divulge or
make known to any person, any information acquired by Executive during the course of his employment, which is treated as confidential
by the Company, and not otherwise in the public domain. The provisions of this Section 12 shall survive the termination of Executive&rsquo;s
employment hereunder for a period of three (3) years. Information will not be deemed to be Confidential Information if: (i) the
information was in Executive&rsquo;s possession or within Executive&rsquo;s knowledge before the Company disclosed it to Executive;
(ii) the information was or became generally known to those who could take economic advantage of it; (iii) Executive obtained the
information from a third party that was not known by Executive to be bound by a confidentiality agreement or other obligation of
confidentiality to the Company or any other party with respect to such information; or (iv) Executive is required to disclose the
information pursuant to legal process (e.g., a subpoena), provided that Executive notifies the Company promptly upon receiving
or becoming aware of such legal process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#9;Executive affirms that he will not
rely upon the protected trade secrets or confidential or proprietary information of any prior employer(s) in providing services
to the Company or its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#9;In the event that Executive&rsquo;s
employment with the Company terminates for any reason, Executive shall deliver forthwith to the Company or destroy any and all
originals and copies, including those in electronic or digital formats, of Confidential Information; provided, however, Executive
shall be entitled to retain (i) papers and other materials of a personal nature, including, but not limited to, photographs, correspondence,
personal diaries, calendars and rolodexes, personal files and phone books, (ii) information showing his compensation or relating
to reimbursement of expenses, (iii) information that he reasonably believes may be needed for tax and estate planning purposes
and (iv) copies of plans, programs and agreements relating to his employment, or termination thereof, with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">13.&#9;Non-Solicitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#9;Executive agrees and acknowledges
that the restrictions set forth herein are reasonable and necessary and do not impose undue hardship or burdens on Executive. Executive
also acknowledges that the products and services developed or provided by the Company, its affiliates and/or its clients or customers
are or are intended to be sold, provided, licensed and/or distributed to customers and clients primarily in and throughout the
United States (the &ldquo;Territory&rdquo;) (to the extent the Company comes to operate, either directly or through the engagement
of a distributor or joint or co-venturer, or sell a significant amount of its products and services to customers located, in areas
other than the United States during the term of the Employment Period, the definition of Territory shall be automatically expanded
to cover such other areas), and that the Territory, scope of prohibited competition, and time duration set forth in the non-competition
restrictions set forth below are reasonable and necessary to maintain the value of the Confidential Information of, and to protect
the goodwill and other legitimate business interests of, the Company, its affiliates and/or its clients or customers. The provisions
of this Section 13 shall survive the termination of Executive&rsquo;s employment hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#9;Executive hereby agrees and covenants
that he shall not without the prior written consent of the Company, directly or indirectly, in any capacity whatsoever, including,
without limitation, as an employee, employer, consultant, principal, partner, shareholder, officer, director or any other individual
or representative capacity (other than (i) as a holder of less than ten (10%) percent of the outstanding securities of a Company
whose shares are traded on any national securities exchange or (ii) as a limited partner, passive minority interest holder in a
venture capital fund, private equity fund or similar investment entity which holds or may hold an equity or debt position in portfolio
companies that are competitive with the Company; provided however, that Executive shall be precluded from serving as an operating
partner, general partner, manager or governing board designee with respect to such portfolio companies), or whether on Executive&rsquo;s
own behalf or on behalf of any other person or entity or otherwise howsoever, engage in the activities described in Paragraphs
(1), (2) and (3) below during the Employment Period and one (1) year following the end of the Employment Period, within the Territory:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&#9;Recruit, solicit or hire, or attempt
to recruit, solicit or hire, any employee, or independent contractor of the Company to leave the employment (or independent contractor
relationship) thereof, whether or not any such employee or independent contractor is party to an employment agreement, for the
purpose of competing with the business of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(2)&#9;Attempt in any manner to solicit
or accept from any customer of the Company, with whom Executive had significant contact during Executive&rsquo;s employment by
the Company (whether under this Agreement or otherwise), business of the kind or competitive with the business done by the Company
with such customer or to persuade or attempt to persuade any such customer to cease to do business or to reduce the amount of business
which such customer has customarily done or might do with the Company, or if any such customer elects to move its business to a
person other than the Company, provide any services of the kind or competitive with the business of the Company for such customer,
or have any discussions regarding any such service with such customer, on behalf of such other person; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(3)&#9;Interfere with any relationship,
contractual or otherwise, between the Company and any other party, including, without limitation, any supplier, distributor, co-venturer
or joint venturer of the Company, for the purpose of soliciting such other party to discontinue or reduce its business with the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">With respect to the activities described
in Paragraphs (1), (2) and (3), above, the restrictions of this Section 13(b) shall continue during the Employment Period and one
(1) year after the end of the Employment Period; provided, however, that if Executive&rsquo;s employment is terminated by Executive
for Good Reason or by the Company without Cause, then the restrictions of this Section 13(b) shall terminate concurrently with
the end of the Employment Period and shall be of no further effect. In the event that any provision of this Section 13 is determined
by a court to be unenforceable, such provision shall not render the entire Section unenforceable but, to the extent possible, shall
be appropriately adjusted to render such provision enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">14.&#9;Inventions. All systems, inventions,
discoveries, apparatus, techniques, methods, know-how, formulae or improvements made, developed or conceived by Executive during
Executive&rsquo;s employment by the Company that (i) are directly relevant to the Company&rsquo;s business as then constituted,
(ii) are developed as a part of the tasks and assignments that are the duties and responsibilities of Executive, and (iii) were
created using substantially the Company&rsquo;s resources, such as time, materials and space, shall be and continue to remain the
Company&rsquo;s exclusive property, without any added compensation or any reimbursement for expenses to Executive, and upon the
conception of any and every such invention, process, discovery or improvement and without waiting to perfect or complete it, Executive
promises and agrees that Executive will immediately disclose it to the Company and to no one else and thenceforth will treat it
as the property and secret of the Company. Executive will also execute any instruments requested from time to time by the Company
to vest in it complete title and ownership to such invention, discovery or improvement and will, at the request of the Company,
do such acts and execute such instruments as the Company may require, but at the Company&rsquo;s expense (and if requested following
the term of this Agreement, then at the customary hourly rate for time requested and spent), to obtain patents, trademarks or copyrights
in the United States and foreign countries, for such invention, discovery or improvement and for the purpose of vesting title thereto
in the Company, all without any reimbursement for expenses (except as provided in Section 9 or otherwise) and without any additional
compensation of any kind to Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">15.&#9;Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The provisions of this Agreement are intended
to comply with Section 409A of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;) and any final regulations
and guidance promulgated thereunder (&ldquo;Section 409A&rdquo;) or an exemption thereunder and shall be construed and administered
in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A. The Company and Executive agree
to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary,
appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under
Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">To the extent that Executive will be reimbursed
for costs and expenses or in-kind benefits, except as otherwise permitted by Section 409A, (a) the right to reimbursement or in-kind
benefits is not subject to liquidation or exchange for another benefit, (b) the amount of expenses eligible for reimbursement,
or in-kind benefits, provided during any taxable year shall not affect the expenses eligible for reimbursement, or in-kind benefits
to be provided, in any other taxable year; provided that the foregoing clause (b) shall not be violated with regard to expenses
reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related
to the period the arrangement is in effect and (c) such payments shall be made on or before the last day of the taxable year following
the taxable year in which Executive incurred the expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A termination of employment shall not be
deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits upon
or following a termination of employment unless such termination constitutes a &ldquo;Separation from Service&rdquo; within the
meaning of Section 409A and, for purposes of any such provision of this Agreement references to a &ldquo;termination,&rdquo; &ldquo;termination
of employment&rdquo; or like terms shall mean Separation from Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any payments under this Agreement that may
be excluded from Section 409A either as separation pay due to an involuntary separation from service or as a short-term deferral
shall be excluded from Section 409A to the maximum extent possible. Each installment payable hereunder shall constitute a separate
payment for purposes of Treasury Regulation Section 1.409A-2(b), including Treasury Regulation Section 1.409A-2(b)(2)(iii). Each
payment that is made within the terms of the &ldquo;short-term deferral&rdquo; rule set forth in Treasury Regulation Section 1.409A-1(b)(4)
is intended to meet the &ldquo;short-term deferral&rdquo; rule. Each other payment is intended to be a payment upon an involuntary
termination from service and payable pursuant to Treasury Regulation Section 1.409A-1(b)(9)(iii), et. seq., to the maximum extent
permitted by that regulation, with any amount that is not exempt from Code Section 409A being subject to Code Section 409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Notwithstanding anything to the contrary
in this Agreement, if Executive is a &ldquo;specified employee&rdquo; within the meaning of Section 409A at the time of Executive&rsquo;s
termination, then only that portion of the severance and benefits payable to Executive pursuant to this Agreement, if any, and
any other severance payments or separation benefits which may be considered deferred compensation under Section 409A that is payable
on account of the Executive&rsquo;s termination (other than by reason of death) (together, the &ldquo;Deferred Compensation Separation
Benefits&rdquo;) that are due to Executive on or within the six (6) month period following Executive&rsquo;s termination will accrue
during such six (6) month period and will become payable in one lump sum cash payment on the date six (6) months and one (1) day
following the date of Executive&rsquo;s termination of employment. All subsequent Deferred Compensation Separation Benefits, if
any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein
to the contrary, if Executive dies following termination but prior to the six (6) month anniversary of Executive&rsquo;s termination
date, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable
after the date of Executive&rsquo;s death and all other Deferred Compensation Separation Benefits will be payable in accordance
with the payment schedule applicable to each payment or benefit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">16.&#9;Excess Parachute Payments under Code
Section 280G. Notwithstanding any other provisions of this Agreement, if any &ldquo;payments&rdquo; (including, without limitation,
any benefits or transfers of property or the acceleration of the vesting of any benefits) in the nature of compensation under any
arrangement that is considered contingent on a Change in Control for purposes of Section 280G of the Code, together with any other
payments that Executive has the right to receive from the Company or any corporation that is a member of an &ldquo;affiliated group&rdquo;
(as defined in Section 1504(a) of the Code without regard to Section 1504(b) of the Code) of which the Company is a member, would
constitute a &ldquo;parachute payment&rdquo; (as defined in Section 280G(b)(2) of the Code), such &ldquo;payments&rdquo; may, at
Executive&rsquo;s sole election, be reduced to the largest amount as will result in no portion of such &ldquo;payments&rdquo; being
subject to the excise tax imposed by Section 4999 of the Code. The type of payments to be electively reduced under this paragraph,
if any, will be at the discretion of Executive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">17.&#9;Miscellaneous.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(a)&#9;Executive acknowledges that the services
to be rendered by him under the provisions of this Agreement are of a special, unique and extraordinary character and that it would
be difficult or impossible to replace such services. Furthermore, the parties acknowledge that monetary damages alone would not
be an adequate remedy for any breach by Executive of Section 12 or Section 13 of this Agreement. Accordingly, Executive agrees
that any breach by Executive of Section 12 or Section 13 of this Agreement shall entitle the Company, in addition to all other
legal remedies available to it, to apply to any court of competent jurisdiction to seek to enjoin such breach. The parties understand
and intend that each restriction agreed to by Executive hereinabove shall be construed as separable and divisible from every other
restriction, that the unenforceability of any restriction shall not limit the enforceability, in whole or in part, of any other
restriction, and that one or more or all of such restrictions may be enforced in whole or in part as the circumstances warrant.
In the event that any restriction in this Agreement is more restrictive than permitted by law in the jurisdiction in which the
Company seeks enforcement thereof, such restriction shall be limited to the extent permitted by law. The remedy of injunctive relief
herein set forth shall be in addition to, and not in lieu of, any other rights or remedies that the Company may have at law or
in equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(b)&#9;Neither Executive nor the Company
may assign or delegate any of their rights or duties under this Agreement without the express written consent of the other; provided,
however, that the Company shall have the right to delegate its obligation of payment of all sums due to Executive hereunder, provided
that such delegation shall not relieve the Company of any of its obligations hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(c)&#9;During the term of this Agreement,
the Company (i) shall indemnify and hold harmless Executive and his heirs and representatives as, and to the extent, provided in
the Company&rsquo;s bylaws and (ii) shall cover Executive under the Company&rsquo;s directors&rsquo; and officers&rsquo; liability
insurance on the same basis as it covers other senior executive officers and directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(d)&#9;This Agreement constitutes and embodies
the full and complete understanding and agreement of the parties with respect to Executive&rsquo;s employment by the Company, supersedes
all prior understandings and agreements, whether oral or written, between Executive and the Company, and shall not be amended,
modified or changed except by an instrument in writing executed by the party to be charged. The invalidity or partial invalidity
of one or more provisions of this Agreement shall not invalidate any other provision of this Agreement. No waiver by either party
of any provision or condition to be performed shall be deemed a waiver of similar or dissimilar provisions or conditions at the
same time or any prior or subsequent time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(e)&#9;This Agreement shall inure to the
benefit of, be binding upon and enforceable against, the parties hereto and their respective successors, heirs, beneficiaries and
permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(f)&#9;The headings contained in this Agreement
are for convenience of reference only and shall not affect in any way the meaning or interpretation of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(g)&#9;All notices, requests, demands and
other communications required or permitted to be given hereunder shall be in writing and shall be deemed to have been duly given
when personally delivered, sent by registered or certified mail, return receipt requested, postage prepaid, or by reputable national
overnight delivery service (e.g. Federal Express) for overnight delivery to the Company at its principal executive office or to
Executive at his address of record in the Company&rsquo;s records, or to such other address as either party may hereafter give
the other party notice of in accordance with the provisions hereof. Notices shall be deemed given on the sooner of the date actually
received or the third business day after deposited in the mail or one business day after deposited with an overnight delivery service
for overnight delivery.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(h)&#9;This Agreement shall be governed
by and construed in accordance with the internal laws of the State of Illinois without reference to principles of conflicts of
laws and each of the parties hereto irrevocably consents to the jurisdiction and venue of the federal and state courts located
in &#9;Chicago, Illinois.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(i)&#9;This Agreement may be executed simultaneously
in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one of the same
instrument. The parties hereto have executed this Agreement as of the date set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(j)&#9;Executive represents and warrants
to the Company that he has the full power and authority to enter into this Agreement and to perform his obligations hereunder and
that the execution and delivery of this Agreement and the performance of his obligations hereunder will not conflict with any agreement
to which Executive is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(k)&#9;The Company represents and warrants
to Executive that it has the full power and authority to enter into this Agreement and to perform its obligations hereunder and
that the execution and delivery of this Agreement and the performance of its obligations hereunder will not conflict with any agreement
to which the Company is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Remainder of page intentionally left blank;
signature page follows.]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">IN WITNESS WHEREOF, Executive and the Company
have caused this Executive Employment Agreement to be executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>THE COMPANY:</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">STRATUS MEDIA GROUP, INC.</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">By:&#9;<U>/s/ Jerold Rubinstein&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&#9;Name:&#9;Jerold Rubinstein</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&#9;Title:&#9;CEO</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><B>EXECUTIVE:</B></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><U>/s/ Stephen M. Simes&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Stephen M. Simes</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RELEASE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&#9;Definitions. I intend all words used
in this Release to have their plain meanings in ordinary English. Technical legal words are not needed to describe what I mean.
Specific terms I use in this Release have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#9;&ldquo;I,&rdquo; &ldquo;me,&rdquo;
and &ldquo;my&rdquo; include me, Stephen M. Simes, and anyone who has or obtains any legal rights or claims through me, including
my heirs and estate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#9;&ldquo;Employer,&rdquo; as used in
this Release, shall at all times mean Stratus Media Group, Inc. and &ldquo;Released Party&rdquo; or &ldquo;Released Parties&rdquo;,
individual and collectively, means the Employer and the Employer&rsquo;s parent, subsidiaries, affiliates, present or former officers,
directors, shareholders, employees, agents or attorneys, successors, predecessors, assigns, or personal representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#9;&ldquo;My Claims&rdquo; mean actions
or causes of action, suits, claims, charges, complaints, contracts (whether oral or written, express or implied from any source),
and promises, whatsoever, in law or equity, that I ever had, may now have or hereafter can, shall or may have against the Employer
or other Released Party as of the date of the execution of this Release, including all unknown, undisclosed and unanticipated losses,
wrongs, injuries, debts, claim or damages to me for, upon, or by reason of any matter, cause or thing whatsoever, that are in any
way related to my employment with or separation (termination of employment) from the Employer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">By signing this Release, I am agreeing to
release any actual and potential claim I have or may potentially have, either as an individual or standing in the shoes of the
government, under any federal, state or local law, administrative regulation or legal principle (except as provided in Paragraph
4 of this Release). The following listing of laws and types of claims is not meant to, and shall not be interpreted to, exclude
any particular law or type of claim, law, regulation or legal principle not listed. I understand I am releasing all my Claims,
including, but not limited to, claims for invasion of privacy; breach of written or oral, express or implied, contract; fraud or
misrepresentation; and any claim under the Age Discrimination in Employment Act of 1967 (&ldquo;ADEA&rdquo;), 29 U.S.C. &sect;
626, as amended, the Older Workers Benefit Protection Act of 1990 (&ldquo;OWBPA&rdquo;), 29 U.S.C. 626(f), Title VII of the Civil
Rights Act of 1964 (&ldquo;Title VII&rdquo;), 42 U.S.C. &sect; 2000e, et seq., the Americans with Disabilities Act Amendments Act
(&ldquo;ADAAA&rdquo;), 29 U.S.C. &sect; 2101, et seq., the Family and Medical Leave Act (&ldquo;FMLA&rdquo;), 29 U.S.C. &sect;
2601 et seq., the Employee Retirement Income Security Act of 1974 (&ldquo;ERISA&rdquo;), as amended, 29 U.S.C. &sect;&sect; 1001,
et seq., Equal Pay Act (&ldquo;EPA&rdquo;), 29 U.S.C. &sect; 206(d), the Worker Adjustment and Retraining Notification Act (&ldquo;WARN&rdquo;),
29 U.S.C. &sect; 2101 et seq., the False Claims Act, 31 U.S.C. &sect; 3729 et seq., the Illinois Human Rights Act &sect;775 ILCS
5, any other state human rights or fair employment practices act, and any other federal, state, or local statute, law, rule, regulation,
ordinance or order. This includes, but is not limited to, claims for violation of any civil rights laws based on protected class
status; claims for assault, battery, defamation, intentional or negligent infliction of emotional distress, breach of the covenant
of good faith and fair dealing, promissory estoppel, negligence, negligent hiring, retention or supervision, retaliation, constructive
discharge, violation of whistleblower protection laws, unjust enrichment, violation of public policy, and all other claims for
unlawful employment practices, and all other common law or statutory claims. To the maximum extent permitted by law, I agree that
I will not seek and waive any right to accept any relief or award from any charge or action against the Employer before any federal,
state, or local administrative agency or federal state or local court whether filed by me or on my behalf with respect to any claim
or right covered by this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.&#9;Agreement to Release My Claims. Except
as stated in Paragraph 4, I agree to give up all My Claims, waive any rights thereunder, and forever discharge the Employer and
all Released Parties of and from any and all liability to me for actions or causes of action, suits, or Claims. To the maximum
extent permitted by law, I agree that I will not seek and I waive any right to accept any relief or award from any charge or action
against the Employer or other Released Party before any federal, state, or local administrative agency or federal state or local
court whether filed by me or on my behalf with respect to any claim or right covered by this Release. I also agree to withdraw
any and all of my charges and lawsuits against Employer or other Released Party, except that I may, but am not required to, withdraw
or dismiss, or attempt to withdraw or dismiss, any charges that I may have pending against the Employer or other Released Party
with the EEOC or other civil rights enforcement agency.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In exchange for my agreement to release
my Claims, I am receiving satisfactory Consideration (compensation) from the Employer to which I am not otherwise entitled by law,
contract, or under any Employer policy. The consideration I am receiving is a full and fair payment for the release of all my Claims.
The Employer and the Released Parties do not owe me anything in addition to what I will be receiving.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.&#9;Older Workers Benefit Protection Act.
[This section may be revised if Executive terminates employment as part of a &ldquo;group&rdquo; termination.] The Older Workers
Benefit Protection Act (&ldquo;OWBPA&rdquo;) applies to individuals age 40 and older and sets forth certain criteria for such individuals
to waive their rights under the Age Discrimination in Employment Act (&ldquo;ADEA&rdquo;) in connection with an exit incentive
program or other employment termination program. I understand and have been advised that this Release of My Claims is subject to
the terms of the OWBPA. The OWBPA provides that an individual cannot waive a right or claim under the ADEA unless the waiver is
knowing and voluntary. I have been advised of this law, and I agree that I am signing this Release voluntarily, and with full knowledge
of its consequences. I understand that the Employer is giving me at least twenty-one (21) days from the date I received a copy
of this Release to decide whether I want to sign it. I acknowledge that I have been advised to use this time to consult with an
attorney about the effect of this Release. If I sign this Release before the end of the twenty-one (21) day period it will be my
personal, voluntary decision to do so, and will be done with full knowledge of my legal rights. I agree that material and/or immaterial
changes to the Separation Agreement or this Release will not restart the running of this consideration period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.&#9;Exclusions from Release. My Claims
do not include my rights, if any, to claim the following: unemployment insurance or workers compensation benefits; claims for my
vested post-termination benefits under any 401(k) or similar tax-qualified retirement benefit plan; my COBRA rights; and my rights
to enforce the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#9;Nothing in this Release interferes
with my right to file a charge with the Equal Employment Opportunity Commission (&ldquo;EEOC&rdquo;) or other local civil rights
enforcement agency, or participate in any manner in an EEOC investigation or proceeding under Title VII, the ADA, the ADEA, or
the EPA. I, however, understand that I am waiving my right to recover individual relief including, but not limited to, back pay,
front pay, reinstatement, attorneys&rsquo; fees, and/or punitive damages, in any administrative or legal action whether brought
by the EEOC or other civil rights enforcement agency, me or any other party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#9;Nothing in this Release interferes
with my right to challenge the knowing and voluntary nature of this Release under the ADEA and/or OWBPA, if I have rights under
such laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#9;I agree that the Employer and the
Released Parties reserve any and all defenses, which any of them has or might have against any claims brought by me. This includes,
but is not limited to, the Employer&rsquo;s or other Released Party&rsquo;s right to seek available costs and attorneys&rsquo;
fees, and to have any monetary award granted to me, if any, reduced by the amount of money that I received in consideration for
this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.&#9;Effective Date; Right to Rescind or
Revoke. I understand that insofar as this Release relates to my rights under the Age Discrimination in Employment Act (&ldquo;ADEA&rdquo;),
it shall not become effective or enforceable until seven (7) days after I sign it. I also have the right to rescind (or revoke)
this Release insofar as it extends to potential claims under the ADEA by written notice to Employer within seven (7) calendar days
following my signing this Release (the &ldquo;Rescission Period&rdquo;). Any such rescission (or revocation) must be in writing
and hand-delivered to Employer or, if sent by mail, postmarked within the applicable time period, sent by certified mail, return
receipt requested, and addressed as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A.&#9;post-marked within the seven (7) day
Rescission Period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">B.&#9;properly addressed to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">[INSERT NAME AND ADDRESS]; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">C.&#9;sent by certified mail, return receipt
requested.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.&#9;I Understand the Terms of this Release.
I have had the opportunity to read this Release carefully and understand all its terms. I have had the opportunity to review this
Release with my own attorney. In agreeing to sign this Release, I have not relied on any statements or explanations made by the
Employer or its attorneys. I understand and agree that this Release and the attached Agreement contain all the agreements between
the Employer (and any other Released Party) and me. We have no other written or oral agreements. I understand this Release is a
very important legal document and I agree to be bound by the terms of this Release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 6%">&nbsp;</TD>
    <TD STYLE="width: 34%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>Dated: ____________, 20__</TD>
    <TD>_______________________________</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Stephen M. Simes</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"></P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>restorgenex_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in"><B>EXHIBIT 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: Red"><IMG SRC="image_001.jpg" ALT=""><B></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">RestorGenex Names Stephen M. Simes
as Chief Executive Officer</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago, Illinois (March 10, 2014) - RestorGenex (OTCBB: SMDID)
announced today that it has named Stephen M. Simes as its Chief Executive Officer, to lead the company. Mr. Simes formerly served
as vice chairman, president, and CEO at BioSante Pharmaceuticals, Inc., a publicly held pharmaceutical company focused on developing
products for women&rsquo;s and men&rsquo;s health and oncology that merged with ANI Pharmaceuticals, Inc. in 2013.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RestorGenex is a biopharmaceutical company with an initial focus
on dermatology, ocular diseases and women&rsquo;s health.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;We are extremely pleased that Stephen has joined our
team to lead RestorGenex, a newly integrated biopharmaceutical company,&rdquo; said Sol J. Barer, chairman of the board of RestorGenex.
&ldquo;His extensive leadership, strategic and technical experience in managing publicly held biopharmaceutical companies will
be a great asset to the company. RestorGenex has several unique opportunities to create substantial stockholder value, and we look
forward to working with Stephen to expand these programs and drive innovation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Simes added, &ldquo;I am excited by the opportunities in
RestorGenex, especially given the people involved and the technologies and products that are forming the basis of the company.
I look forward to working with the RestorGenex team to bring better products to patients in need.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Before BioSante, Mr. Simes was president, CEO, and a member
of the board of directors for Unimed Pharmaceuticals, Inc., which is now a subsidiary of AbbVie, Inc. Previously, he served as
senior vice president and director of Savient Pharmaceuticals Inc., following its acquisition of Gynex Pharmaceuticals, of which
he was president and CEO. Mr. Simes&rsquo; career in the pharmaceutical industry started with G.D. Searle &amp; Co. (now a part
of Pfizer Inc.). Mr. Simes earned his MBA in Marketing and Finance from New York University, having earlier received a Bachelor
of Science degree in Chemistry at Brooklyn College of the City University of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr. Simes replaces Jerold Rubinstein who resigned as chief executive
officer effective with Mr. Simes&rsquo; appointment. Mr. Rubenstein remains a director and chairman of the Audit Committee. &ldquo;We
would like to thank Mr. Rubinstein for the important role he played in the company&rsquo;s recent transition,&rdquo; said Sol J.
Barer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">Forward-Looking Statements</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Statements in this press release relating to plans, strategies,
projections of results, and other statements that are not descriptions of historical facts may be forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Acts of 1933 and 1934. Forward-looking information
is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due
to a number of factors. Although the company's management believes that the expectations reflected in the forward-looking statements
are reasonable, it cannot guarantee future results, performance or achievements. The company has no obligation to update these
forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Contacts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RestorGenex</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Tim Boris, 310-526-8700</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">timb@stratusmediagroup.com</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0$`>`!X``#_VP!#``8$!08%!`8&!08'!P8("A`*"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!#`0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P``1"`#)`>8#`2(``A$!`Q$!_\0`
M'0`!``(#`0$!`0````````````8'!`4(`P$)`O_$`%L0``$#`@($!P@*#0@)
M!0````$``@,$!081!Q(A,0@305%A<9$4(G*!H;&RT18R,S4V0E)SDL$5%Q@C
M0U155G24HK/")#0W4V*"D\,F.&-D=96CTO`E16:EX__$`!D!`0`#`0$`````
M```````````"`P0!!?_$`"\1``("`0,"!0,$`P`#```````!`@,1!"$Q$D$3
M%#(S46%QD05"4H&AL?`5T>'_V@`,`P$``A$#$0`_`.J41$`1$0!$1`$1$`1$
M0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$)`
M&9.06)-<Z"#W:MI8_#E:/.5U)O@XVER9:+428FLL?MKE3'P7ZWF6,_&-A;ON
M#?%&\^8*:JL?$7^"+M@N9(D"*.'&U@!V5Q/5"_\`[5_0QI8#_P"X#QPR#^%=
M\"S^+_!SQJ_Y+\DA1:6+%-DE]K<H!X1+?.MA37&BJLA35E/,3_5RM=YBHNN4
M>424XOAF4B(H$@B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(
M@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B+X][8V%\C@UHVDN.0"`^HH_<<866
MAS#JMLSQ\6`:_EW>51FX:1W',6ZA`YGSNS_9'K5\--;/A%,]17#EEC+QJ:JG
MI6:]5/%"SGD>&CRJFZ_%U[K,PZM?$P_%A&IEXQM\JT<LCY7E\KW/>=[G',E:
MH?I\OW,S2UZ_:BY*W&ECI<QW7QSA\6%A=Y=WE6BK-)$`S%';Y'\QE>&^09^=
M5[34555'^34T\WS<9=YEM:?"5\J,M2WRM'^T(9YR%<M)1#U/\LI>JOGZ5^$;
M.KT@7>;,0MIH!R:K-8^4GS+45.)[U4Y\9<J@9_U;M3T<EMH-']YDRUW4L7AR
M$^8%9T6C>J/NUPA;X+"[U*2GIH<8(N&HGSD@\]3/.<YYI)3SO<7>=>2L>/1K
M&/=+HX^#!E_$O8:-Z39K5\YZF!2\Y2N'_@CY2Y\HK)%9QT<47)75`ZVM7F_1
MM`?<[E(WPH@?K">=I^1Y.WX*U13^;1M4#W"XQ/\`#C+?,2M=4X`O,0)C[FGZ
M&29']H!36JJ?$B#TUJ_:1%%M*ZP76A!-503L:-[@W6:/&,PM6KE)2W3*G%QV
M:-C07NYT!'<E=/&!\77S;V'8I;9](D\9:R[4[96<LL/>N'6-Q\B@**NRBNSU
M(LA=.'I9?UKN5)=*83T,[98^7+>T\Q'(LM4+9;K56>M94T;RUP]LT^U>.8A7
M;9;E#=K;#64^QL@VM.]KN4%>3J=,Z7E<'J:?4*U8?)FHB+*:0B(@"(B`(B(`
MB(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(CB&M)<0`-I)
MY$`11R[8RL]OUFB?NF4?$@[[R[O*H?<L?W.L?Q5M@93!VP$#C'GZO(M%>ELG
MPL?<HGJ:X<LL^>:*GC,D\K(HQO<]P:!XRHU=,<VBCS;"]]7(.2(=[]([.S-0
M:/#V)+Y*):F.<Y_A*I^KEU`[<NH+?V_1P-CKC7$\[(&_Q'U*]445^Y+/V*7=
M=9[<<?<UEST@W*HS;1114C.0Y:[NT[/(H[+/=+U-D]U76O\`DC6?EU`;E;-!
MA&R461;1,E>/C3'7S\1V>1;V*-D3`R)C6,&YK1D`I>;JK]N!'RMEGN2*<HL%
M7RJR)I1`T_&F>&^3:?(M[1Z-Y#D:VX,;SMBC)\IR\RLA%5+76RXV+(Z*M<[D
M3H\`V:#(S-GJ3_M),A^SDMW26.UTF7<]OIF$?&XL%W:=JV*+/*ZR7++XU0CP
M@``,AL"(BK+`B(@"(B`(B(`B(@"UUQL=LN(/=E%#(X_'U<G?2&U;%%U2<7E,
MXXJ6S*[OFCP!KI;-.2=_$S'?U.]?:H!5TTU'4/@JHGQ3,.3F.&1"Z#6AQ=AZ
M&^T+@&M;6Q@F*3^$]!\BWT:V2?39NC%?HXM9KY*45A:)JUPFKJ%Q[TM$S1S$
M;#YV]BK^6-\4KXY&EKV$M<T[P1O"ENB[/V2NRW=SOSZLVK=JDI52,6F;C:BV
MD1%X)[81$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1
M:>\8CMMJ/%SS<94;A!$-=Y/-ER>-2C%R>(HC*2BLMFX6'<KI0VR/7KZF.$;P
M'':>H;RHQ)58HO?>T-,VTTCOPDQ^^$=668[/&O[H<"439>/NM1/7SG:XO<6M
M)[<SVJY50C[DOZ6__P`*G9*7MK^V8-QQ\^>4T]AH9)Y3L#Y&DY]31M\JU[K#
MBG$+@ZZ3F"$[=25V0\3&_7DK&HJ*EH8N+HZ>*!G-&T#-9"DM1&'M1Q]7NR+H
ME/W)9^A#+;H^MM/DZMEFJW\HSU&]@V^52B@MM%;V:M%2PP#E+&`$]9WE9:*F
M=T[/4RV%4(>E!$15E@1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0%/:1Z-
MM)B>5S!DVH8V;(<YV'R@GQK<Z)J,FHKJTCO6M$+3SYG,^8=JQ]*PUKW1,8"9
M#!N&\]\<E.<)VK[#V.GIG`"8C7E\,[^S8/$O3MMQIHKNSSJZLZAOLC;HB+S#
MT0B(@"(B`(B(`B(@"(H_C*_2V"CIYH862F234(>2,MF:E"#G+ICR1G-074R0
M(JR^V16?B%/](I]LBL_$*?Z16GR5WP9_.5?)9J*MH-),P>./MT;F\NI(0?*"
MIM8+W27RD,U&YP+3D^-^QS#T^M56:>RM9DMBRN^NQXBS9HB*DN"(B`(B(`B(
M@"(B`(B(`L2LK13N$<4,U1.1F(XF^=QV#QE9:+JQW./Z&CEH+G<OY]6=Q4Y_
M`49[XC^U(?J`69;+-;[8/Y%2QQNY7Y9O/6X[5L$4G9)K'8BH)//<(B*!,(B(
M`B(@"(B`(B(`B+SJ9XJ6FEJ*F1D4$3#))(\Y-:T#,DGD`"`]$7.>+^$AQ-;+
M!A2TQ3P,)`JJUS@).D,;D0.LY]`47^Z+QF_:RW63+HIY3_F+7'16M9P9GJZT
M\9.M$7)K.$?BYCOOMML;ARCB90?WBL[17IQH<7W2*SWBB%MN4VR!['ZT4SOD
M[=K7<P.>?/GD%&>DM@NIH[#4UR>$RY$1%F-`1$0!$1`$1$`1$0!$1`12.TNN
M>,Y[E5,(IJ(-B@#A[=X&9/4"3X^I2M$4YS<\9[$(04<_4(B*!,(B(`B(@"(B
M`(B(`H-I9]ZJ+Y\^B5.5!M+/O51?/GT2M&E]Z)1J?:D9NCREIY<+4SY8(GN+
MG[7,!/MBI)W#2?BL'^&%&M'M73Q86IF2U$+'AS\VN>`?;%23N^C_`!NG_P`0
M>M<OZO$E]Q3T^''[&)=+';Z^CEADHX-9S2&O#`'-/(057.C"=\6)#$"=2:%S
M7#JVCS*P[OB&VVZDEE?5P/D:TEL;'ASG'D&05?Z+J5\V()*@`\7!$<W=)V`>
M?L6BCJ\&?5P47=/C0Z>2UUJ<6R/APW<)(7NCD;$2'-.1'45MEIL9?!>Y?,E8
MZO6ON:[/0_L5S8*'$-\@EEHKG,&QNU3QE2\'/+/I6T]BV*_RH?UN3U+8Z)O>
MNN^>'HJ=+;?J95V.*2_!DIT\9P4FW^2`6C#F):>Z4DU5<3)3QRM=(WNE[LV@
M[1D1M4_1%CMM=CRS574JUA$>QO>Y+):!)39=TS.XN,D9ZNS,G+_S>H5;;#B+
M$%,VMDKW,BDVM,TSLW#G`&X=BW.EICC0V^0`ZC9'-)Z2!EYBI#@VMIZG#M`V
M&5A?'"V-[`1FT@9',+5"7A4*<%NV9I1\6YPD]DB(>P6]MVQW.'6^<>/J7E8[
MS=K#B..UW>9\L+WMC<'OU]76W.:3R;?_``JT%';SA2ENMWCN$T\[)6:O>LRR
M.J<^9<AJNO,;>/L=EINC$JN21*)XTM5ZN%33.L]0^*-C"'ALQCS.?1O4L19:
MYNN74C3."G'I95D^'\60022R5TVI&TO=E5NW`9\ZUEBBQ!>W3-H:^I)B`+M>
MI<W?GER]"MN\>]-;\P_T2H%HC]WN?@Q^=R]"&HE*J4VEE8,,Z%&R,$WAG@,-
MXN!&==+^N.]:L]$6&VYVXRN#952J\X-#C.^FQ6KC8@UU3*[4B!W`\I/5ZE":
M&RXFQ#3MK)*YS(I-K>.F<W,<X:T;!V+*TMO)J[='GL#'N[2/4K"MK&Q6ZEC8
M,FMB8T#H`"TJ7@51E%;LSN/C6RC)[(KKV"7S>+E!G\Z_U+%K(\2X2=%4259E
MIR[5V2&2,GF(.Y6NH[I!8'X2KLQM;J.'0==J5ZJ4Y*,TFF=LTT81<HMIHVEC
MN,=VM5/6Q#5$K<RWY)&PCM6<H=HKD+\.2M)V,J7`=6JT_65,5EN@H3<4:*I=
M<%)E48EJ+G48UJ*"BKJB+C)&L8T3.:T$M'-N69[%L5_E0_K<GJ6/7?TIM_28
M_1:K36VVYU1@HI<(QU5*UR<F^2LW89Q=$"^.Y/<X;@VK?F>W8LW!&)JZ2[.M
M%X)?+WS6/<,G-<W>T\^XJ?JJX@':4CQ6W^4NSRZ&G/ZU&NSQXR4TMEDE.'@2
MBX-[LM15/PF[Q+:]%\T,#RUUPJ8Z1Q&_5R<]W:&9>-6PJ)X7+C[#+,WD-PS_
M`.F_UK/IEFV*9HU#Q7(\."SA.V.PK4W^LHX:BOFJ71122L#N*C8![7/<22<S
MT!7Z``````.0*JN#*W5T34)^543G]LCZE:,\T5/&9)Y611C>Y[@T=I34R<K9
M9%"2K0J*>&IC,=1%'+&=A;(T.!\17%VF*WP83TRU7V&B92PQ305<,<8U6QN+
M6N.0Y!K9G+D79'V6MWY0I/\`&;ZUY25MGE?K25-O>\\KI&$KNGM=+;QDY=4K
M5C.#9(B+.7G%6$_9SC;%5=:K)B6XQSQ-DG^_W&9C0QKPW(9$_*"G'VJ-+?YU
MN_YO4>I:W@Q?TN7;]!G_`'T:ZO7I:F^54^F*7X,&GI5D.J39S%]JC2W^=;O^
M;U'J72=IAFI[71PU3]>HCA8R1VL3K.#0"<SOVK*18K;I68R:JZE7P:S$\CXL
M-7:2)[F2,I)G-<TY%I##D05Q%:L78T@:Z[TM\O$T-!-$9#)5R/8"XG5#VEV1
M:=4C;LY.5=MXL^"MY_0IO0*YKX+UHH[]#C*UW*(2T=72PQ2-Y<B7[1S$'(@\
MA`6K2R4*Y2:SP4:F+E.,4\<G1&`,4TF,L*T5YHLF\:W5FBSS,4H]LP]1W<X(
M/*I"N5=&MWK-$.E*MPO?Y2+362",RNV,!/N4XY@0<G<W+[5=5+/?5X<MN'P7
M4V=<=^5R<QZ1+_>*;A'T%OI[M<(J!U=;VFFCJ7MB(=Q>L"T'+(YG/GS73BY0
MTF?ZT%N_XA;O\I=7JS4I*,/L0T[S*?W-1C"62'"5[EA>Z.5E#.YCV'(M(C<0
M0>0KD71Y0:0<>R5S+'B>O8:,,,G=%RF9[?6RRRS^25UQC7X&W[]`J/W;E0?`
M^_G>*O`IO/*I:>713.2Y6"-\>JV,7]3'^U1I;_.MW_-ZCU+)MNBW2M!<:66H
MQ0Y\$<K'2-^RLYS:""1EEMV+I1%#S<_A?@GY6'R_R%66G;#5ZN^&C<L+W&XT
METM[2\PTM0^,5$>]S<FD9N&\>,<H5FHJ(3<)*2+IQ4UTLHW@X:2I+_1.PW?J
ME\MVIFE]/-*[-U1%R@D[W-\HZB5>2Y7T\8+J\"XLIL987UJ>DFG$KC&-E-49
MY[ODNV[-V\;B`M_CO3I3UFC*E%C?Q.(+DPPU#&G;1Y;'N!Z<^]/,<]X6NRCQ
M6IU</_!EKN\-.%G*_P`FITQZ0;SBO'5)A7`M951L@FXCC*.9T9J)SL/?-/M&
M[>C>=V2Z$P79),/8;H[=4UU3<*J-N<]542ND=)(?;'-Q)`Y`.0`*I^#3H[^P
MMJ&*+O#E<JYF5*QXVPPGXW0YWHY<Y5YJO43BL50X7^6641D\V3Y81$64T!0;
M2S[U47SY]$J<J#:6?>JB^?/HE:-+[T2C4^U(C5@P747FV1UL57%&UY<-5S22
M,CDMC]K>K_'X/H%2?1Q\$Z;PW^D5)E=;J[8S<4^&4U:6N4$VBHKU@>X6RCDJ
MFRPU$40UGAF8<!RG(\BDNC.[Q55/-0=S0P2Q#C`8FY<8-Q)Z1L[5+[H`;95@
MC,&%X/T2JQT5?".;]&=Z35-6.^F77RB+K5%T>CN6NM-C+X+W+YDK<K38R^"]
MR^9*PU>M?<V6>A_8K3"V%9,04TTS*IL`B?J9%FMGLSYUN_M;3?E*/_"/K6?H
MF]ZZ[YX>BITMNHU5L+'&+V,=&FKG6I-;D(PY@B6T7FGKG5S)1%K=X(R,\VD;
M\^E3=$6.RV5KS(V5UQK6(F'=[;376ADI*QA=$_;F#D6GD(/.H%4Z-Y@\]RW"
M,LY!)&01V+/THU-920VZ2CJ9X&ETC7F*0MS/>Y9Y=14IPY4BKL-OF$G&%T#-
M9Q.9+@,CF>?/-7PE936IQ>S*)1KNL<)+=$`^U_>(_<:ZF']][?J6-37.]83O
M<5-<IGR0'(O8YY>US"<M9I.[E[%;*JO2E(V?$--#$0Z1D(:X#D)<<AYNU747
M2OET6+**;Z8TQZX/#+41?&#58T'D&2^KSCT#$O'O36_,/]$J!:(_=[GX,?G<
MI[>/>FM^8?Z)4"T1^[W/P8_.Y:ZO8G_1DM]^']ED(B+(:RLM+7OA0?-.\ZL>
MB_F5/\VWS*`Z6Z=W_IU0!WO?QD\QV$?7V*9X>K(J^RT<\+PX&)H=D?:N`V@^
M-;+=Z(/[F2K:^:^QL5H,>?!*X>"WTVK?J+:2*V*GPU-`YX$M0YK&-SVG)P)/
M8/*J*$W9''R77/%<L_!B:*1_H_4G_>G>@Q31131E3NAPPU[AEQTSY!U;&_PJ
M5J6I>;9'-.L51*?Q.^ICQ]4/H`75396&(`9YNU1EL6U^R6./Q>7]7;ZECUW]
M*;?TF/T6JTUJNM4(P3BGLN3+34YRDU)K?L5;6W3&C:=YFCJ8XP.^<RG;F!U@
M9A>VC&&@EN4M1+/(^Y-:2UCVY#([W`Y[3MZ-ZLQ55AUH@TFOBB&K&*BH:&C=
MED_8D+%;7.*6-NQV=;KL@V\[]RU51/"Y'^AME/\`O_\`EN5[*G^%+:I;AHT;
M4P,+NX*R.>3+D80YA\KVK+IGBV)IU"S7(S>#.<]$MOZ)Y_WA4BTLX3J<:X+J
M;+15$-/-+)&\23`ZHU7`G=M5;\%O%EL.$9K!5UD,%PIZE\D<4CPTR1OR.;<]
MY!ULP.CG5\@@C,;0NW]5=SE]3E.)U)?0Y8^YJO\`^6[7]&3U*J](.$JK!&)9
M+/6U,-1/'&R3C(<]7OAF-^U=\331P1.DGD9'&T9N>]P`'62N+]+U;#C/3141
M6:5M5#//!10R1G6;(<FM)!Y1K$[5MTNHLLD^K@R:FB%<5T\G:322T$[\E]1%
MY1Z1PS@#!$N/L:7"TPUS*)T;):CC'QEX(#VMRR!'RO(K,^YFK?SFIOU1W_>M
M5P8OZ7+M^@S_`+Z-=7KTM5J;*Y],7L>?IZ(60S)'-5-P:JV&HBE.):<ACP[+
MN1VW(^$NE418K;IVXZV;*ZHU^E&JQ9\%;S^A3>@5SUP/_?3$WS,'I/70N+/@
MK>?T*;T"N>N!_P"^F)OF8/2>KJO8G_13;[T/[)]PBL`^RK"_V4MT6M>+6TO:
M&C;-#O<SI(]L/&.5?SP<\?>RG#'V)N,NM=[6P,)<=LT.YK^DCVI\1Y5;RY6T
MG6>LT1Z4*+%6'X\K562F01#8P$^ZPGF!!S'-GL]JNTOQH>"^>W_H6KPI^*N.
MYXZ3/]:"W?\`$+=_E+J]<@8KO%'B#A"V&ZVR3C*2KK+;)&[E&?%9@\Q!S!'.
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MV5<VM`9AFR74(.JX<SLCU@')6#@^T7/39I.J;K>==MJA<'U&J3JQQ`]Y`P\Y
MV[?".]=08KPI;,284GP_5PLCHGQ".+BV@<06CO',')J[/-N7I*R.E2KY;Y,#
MK>I;GV['W`V)J'%V&**[VP@13-R?%GMA>/;,/2#VC(\JWRY'T98BK]$.D:LP
M]B0EELGE$50?B,/Q)V]!!&?0><`+K=K@YH<T@M(S!&XA8]13X<MN'P:J+?$C
MORN3ZB(J"X*/8SL,U_HZ>&":.(QR:Y+P=NS+D4A12A-PDI1Y(S@IKI9J<+6N
M2S6:&BFD9(]A<2YN[:25MD1)2<FY/N=C%122/*KB,U+-$T@%['-!/)F,E$L'
M82J;%=)*J>IAE:Z(QZK`<\R0>7J4R12C;*,7%<,A*N,I*3Y06#?:)]QM%51Q
MN:Q\S"T.=N"SD4$VGE$VLK#*S9H\N+!DRX0-'1K!??M?W3\IQ=KE9:+3YVWY
M,WDZO@@%HP3<:*Z4E3+<(GLAE:]S07;0#N4_52Z0,>33:0K!@?#M28ZJ>KC?
M<:B(]]'$#KF)IY'%H))Y!D.4Y6TH7RG+$I]R=,81S&!KK]::>]6Y])4Y@$ZS
M'C>QPW$*">P6]TCG"@N438\^21\9/B`/G5F(N5ZB=:Q'@[91"QY?)6GL/Q._
M8ZZLRZ:F0_4MEAW`G<=='67.I;/)&[7;&P'5+N0DG?U*<HIRU=C6."*TM:>>
M0B(LQH/&NA-115$+2`Z2-S`3R9C)1S!6&I\/R5;IYXI>.#0-0'9EGS]:E**:
MLE&+@N&0=<7)2?*"(B@3,*\6RGN]!)25;28W;01O:>0CI4!ET?W.FE<;;<8M
M0\KG.C=Y`59:*ZJ^=2Q%[%-E$+'F2W*R]AN)?RE'^LR>I9%#H]J):@27>O:Y
MHWB(ESG=&L[++L5BHK'K+.VQ!:2OON>=-!%34\<$#`R*-H:UHY`%Z(BR\FG@
MA]1A2HEQ@+P*B$0B5LG%Y'6R``^I3!$4YV2GCJ[$(5QAG'<*'V_"=338P=>'
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M6@$^1>E'3]S0-C,TTSAM=)*[-SCS\PZ@`.8+V5%M\[?475TQK])AWFD=7V>N
MHXW!KZB"2)KG;@7-(S/:JRT(:+[AH]J[M-<*^EJQ6,C8T0!PU=4N)SS'2K91
M0C9*,7!<,DX)R4GR@H]C["U)C+"U;9J[)HF;G%+EF8I![5XZCV@D<JD***;B
M\HDTFL,YMPMP>[U9\36BYS7FW21T59#4N8UK\W!CPX@;-^Q=)(BLMNE:\R(5
MU1KVB8-_HGW*Q7&AC>UCZJFD@:YVX%S2`3VKFN'@XXC@SXG$-!'GOU!(,^P+
MJ)%VJ^=2:B<LIC9O(YB^YYQ3^<])]*7U+)MN@#$]+<:6HDQ+2/9%*R1S0Z7:
M`0<MRZ416><M^2ORM853Z9]'N(](%124]'=J&CL],-<02!Y=)*=[W9#+8-@'
M7SJV$5%<W7+JCR7S@IKI9&M'F$:+!.%Z6T4(#G,&O/-ED9I3[9Q\P'(``I*B
M*,I.3RSJ2BL(K/31HNAT@4M)/1S0T=WICJMGD:2U\1WL=EMV':.;;SJ0:,;'
M>\-X6@M&(*ZFKWTO>4\T.MGQ7(UV8Y-P/-ES*6(INV3AT/@BJXJ76N0B(JR8
M1$0!$1`$1$`1$0!0W2QC.+`^#JJY=ZZM?]YI(W?'E(.1(Y@,R>K+E4R7'/"4
MQ8[$&/I;=!)G0V@&F8`=AE_".Z\P&_W5HTM7BV8?!1J+?#AE<F!H&K9*K3;9
M*ROE=+//+4/DD><R][H9-IZ22NU5^>.&KO-8<06Z[4NV:CG9.UN>QVJ<\CT'
M=XUW_8;M27VS4=TMLHEI*J,2QN',>0\Q!V$<A!6C]0@U)2[%&BDG%Q,]$1>>
M;@B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"+#NMTM]HI34W6MIJ*G'X2
MHE;&WM)56XHT_81M&O';75-XJ!L`IV:D>?2]V7:`59"J<_2LD)V1AZF6\L*[
M76WV>D=57:MIJ*G&^2HE#&]IY5S-/I=TBXZJGT6#+7W(P[#W)%QKV`_*E?WK
M>O)JW6']`MXOE6VXZ1;_`%$LKMI@BE,TI',Z1V8'4`>M7^64-[98^G+*?,.?
MMQS_`*)7B'3U8*>I%%ABBK<07!YU8V4\98QSN8$C6/B:>M>-';-*&.LI+[<6
M81L[]O<U"/Y2]O2[/-O:/!5CX3P;8,)4W$V"V04I(R=*!K2O\)YS<>K/)2!0
M=L(^W'^W_P!@FJY2];_I$5P;@##V$09+51!]:_/C*VH/&SR$[R7G=GS#(*5(
MBHE)R>6RU145A!$1<.A$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1
M$0!$1`85[KFVNS5]P>,V4E/).1SAK2[ZE^>-742U=5-45#R^:9YD>X[W.)S)
M[5W[I`@?58#Q)3PC.26VU,;0.4F)P"_/U>I^G)8DSSM<]T@K6T):59\#UHM]
MT+Y\/5#\WM&UU.X_'9T<[?&-N^J46^<(V1Z9&*$W!]43]%;5<:.[6^&NME3%
M54DS=:.6)VLUP_\`.19:X%P7CG$&#*HRV&O?#&XYR4[^_BD\)AV9](R/2K\P
MCPC[95!D.*;9+0R[C44OWV(]):>^:.K67DVZ*<-X[H].O5PEZMF7\BCV'\;8
M:Q"UOV'O=!4O=NB$H;)]!V3AV*0K&XN.S-2:>Z"(BX="(B`(B(`B(@"(B`(O
M.>:*GB,D\K(HQO<]P:!XRHM=])&#;3K=VXDMH<W>R*83.']UF94HQ<N$<<E'
MEDM14U>>$1A"BUFV^&XW%_(8X1&P^-Y!\B@%]X2=YGUFV2RT5&T[`^H>Z=W6
M,M4>=7QTELNQ3+4U1[G4BT]^Q/8\/L+KU=J*BV9ALTS6N/4W>?$%Q=?]*>-;
M[K-K+_5LB=LXJE(@;ES=YEGX\U_6&=%^,\4R"6DM%0R&0YFJK/O+#G\;-VUW
MB!5ZT*BLV2P4/6.6U<<E_8EX1&%K=KLLU/67>4;G-;Q,1_O.[[]E53B/3WC*
M]R&GM`I[7&\ZK64L?&2NSY-9V>WP0%.<*<&VDBU)<4W>2H<-IIZ%NHSJ+W;2
M.H!7+A?!>',+1AMBM%+2O`R,H;K2GK>[-Q[5SKTU7I74_P#O^X.]%]GJ>$<L
M6311I`QS5-KKP*BG8_?57:5VN1T-.;_(!TJX\'\'W#%HU)KW)->JH;=63[U"
M#X`.9\9(Z%<J*JS5V3V6R^A;#2PCN]V8]OH:2W4C*6WTT%+3,&38H8PQK>H#
M8LA$64T!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1$0!$1`$1$`1
M$0!$1`'`.!#@"#L(/*N%-+F#9\$XSK*$QN%!*XS44G(Z(G8,^=OM3U=(7=:C
M./\`!=JQQ8W6Z[QD%N;H*AGND#_E-/G&X]BTZ6_P9;\,SZBGQ8[<HX%13S2-
MHOQ!@:9\E;#W5:];5CKH!FPY[@X;V'H.SF)4#7MQG&:S%GDRBXO$@B(I$0MY
M:\6XBM(`ME]N=*T;F153VM[`<EHT7&D^3J;7!8MNTT8]H2`V_/G8/BU$,<F?
MC+<_*I)1<(S%\(`J*2SU(Y2Z%[7>1X'D5+(JGIZGS%%BNL7$CH"GX2]U;_.,
M/4,G@3O9YP5FQ\)R0>Z848[P;AE_EE<Y(H/24O\`:2\U;\G2'W3O_P`1_P#L
MO_R7\2<)R0^YX48W9\:X$_Y87.2+GDZ?X_[.^:M^?]'0,_"8NCL^(P[1,\.H
M<[S`+5U7"/Q9)F*>WV6$<_%2./IY>14DOK6ES@UH)).0`Y5):6I?M./4VON6
MC6Z=\>U.?%7.GI0?ZFDC_B!4<N.DK&EPS%3B:Z`'>(IS$#XF9+(L&BO&M\:Q
M]%8*MD+]HDJ<H&Y<_?D9CJS5BV'@V7FHU7WR\T5$T[2RG8Z=W5MU0/*HN6GK
M^#JC?9\E%UE;5UTG&5M3/42?*ED+SVE?Q3P35,S8::*2:5YR:R-I<XGH`78&
M']`.#+9JOKHZRZRC;_*9BUF?0UF78259-EL-IL</%6:VT=#'ED13PM9GUD#;
MXU3/7P6T%DMCHIOU,XVPWH9QM?=1S;2Z@@=^%KW<2!_=/?\`[*MC#/!LH8=2
M3$MYFJ7;S!1,$;>K7=F2/$%T&BRSUMLN-C3#25QYW(OAC`&%L,:CK-9:2&9N
MZ=[>,E^F[,CQ%2A$624G)Y;-*BHK""(BX="(B`(B(`B(@"(B`(B(`B(@"(B`
M(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`\*ZCI;A224M?3PU-
M-(,GQ3,#V.'2#L*J;%/!_P`)7=SY;8:FSSNVY0.UXL_`=Y@0%<"*<+9U^EX(
M3KC/U(Y2O7!OQ'3.<ZTW2W5T8W"36@>?%DX?M*'7#0UCVA)U\/RRM&YT$T<F
M?B#L_(NWD6J.OM7.&9Y:*M\;'`E3@/%U,3QV&+TT#E[BD([0,E@28;OL6?&6
M6YLRV=]2R#ZE^A2*Q?J,N\2'D5\GYY"P7@G(6FX?JS_4LB+">(ICE%8+N\_V
M:.0_PK]!43_R+_B<\BOY'!=-HYQG4D"/"]X&?]92/C](!;JBT*X^J\B+"Z)O
MRIJB)F7B+L_(NVD47^H3[)$EH8=VSD>W<'3%]1D:NJM-(WE#IGO=V-:1Y5*K
M9P9F#)UTQ*X\[*:ER_:<[ZET<BKEK;7WP6+25+L5%:>#[@FBU351W"XD;^Z*
MG5!_PPU3BS8#PI9=4VW#]MA>W=(8&O>/[SLSY5)45$KK)<MEL:H1X0````&0
M"(BK+`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(
M`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"
M(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B(`B(@"(B`(B
&(`B(@/_9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
